Objective:
To ascertain the
effectiveness of IHC markers of vascular origin like CD31, CD34, FLI1 and ERG in vascular
soft tissue sarcomas including
angiosarcomas, Kaposi
sarcomas, epithelioid hemangioendothelioma and a non-vascular
soft tissue sarcoma [
Epithelioid sarcoma]. Study
Design:
Descriptive study. Place and Duration of Study Shaukat Khanum Memorial
Cancer Hospital and
Research Centre, Lahore, from 2011 to 2017